Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Dasheng Pharmaceutical is a pharmaceutical enterprise based in the Benxi High-tech Industrial Development Zone, a major life sciences hub in China. The company is primarily engaged in the research, development, and large-scale production of chemical active pharmaceutical ingredients (APIs) and finished drug products. Its therapeutic focus spans cardiovascular health, anti-infectives, and gastrointestinal treatments, with a portfolio that includes widely used generic medications such as Pitavastatin Calcium and Rosuvastatin Calcium. Operating with modern, GMP-certified facilities, the company serves both the domestic Chinese market and international partners. Liaoning Dasheng Pharmaceutical plays a key role in the regional "China Medicine Capital" industrial cluster, contributing to the local pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Dasheng Pharmaceutical.